In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Theratechnologies Inc (NASDAQ: THTX) closed at $2.50 in the last session, up 1.63% from day before closing price of $2.46. In other words, the price has increased by $1.63 from its previous closing price. On the day, 0.11 million shares were traded. THTX stock price reached its highest trading level at $2.528 during the session, while it also had its lowest trading level at $2.46.
Ratios:
We take a closer look at THTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on November 17, 2022, initiated with a Overweight rating and assigned the stock a target price of $9.
On July 29, 2021, Canaccord Genuity Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $8 to $3.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THTX now has a Market Capitalization of 114950000 and an Enterprise Value of 160960048. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68. Its current Enterprise Value per Revenue stands at 1.815 whereas that against EBITDA is 10.935.
Stock Price History:
The Beta on a monthly basis for THTX is 0.60, which has changed by 0.9841269 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, THTX has reached a high of $3.13, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -2.03%, while the 200-Day Moving Average is calculated to be 43.56%.
Shares Statistics:
According to the various share statistics, THTX traded on average about 2.98M shares per day over the past 3-months and 150650 shares per day over the past 10 days. A total of 45.98M shares are outstanding, with a floating share count of 19.12M. Insiders hold about 20.99% of the company’s shares, while institutions hold 52.87% stake in the company. Shares short for THTX as of 1748563200 were 245385 with a Short Ratio of 0.08, compared to 1745971200 on 419509. Therefore, it implies a Short% of Shares Outstanding of 245385 and a Short% of Float of 0.7799999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
According to 2 analysts, the current quarter’s revenue is expected to be $24.3M. It ranges from a high estimate of $25.18M to a low estimate of $23.41M. As of the current estimate, Theratechnologies Inc’s year-ago sales were $30.05MFor the next quarter, 2 analysts are estimating revenue of $30.09M. There is a high estimate of $31.67M for the next quarter, whereas the lowest estimate is $28.51M.
A total of 3 analysts have provided revenue estimates for THTX’s current fiscal year. The highest revenue estimate was $116.79M, while the lowest revenue estimate was $112.79M, resulting in an average revenue estimate of $114.71M. In the same quarter a year ago, actual revenue was $122.84MBased on 3 analysts’ estimates, the company’s revenue will be $131.89M in the next fiscal year. The high estimate is $132.66M and the low estimate is $130.53M.
